IDEAYA Biosciences, Inc. (IDYA)
34.57
+0.06
(+0.17%)
USD |
NASDAQ |
Dec 31, 16:00
34.54
-0.03
(-0.09%)
After-Hours: 20:00
IDEAYA Biosciences Cash from Investing (Quarterly): 41.77M for Sept. 30, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Pfizer Inc. | -2.43B |
| Regeneron Pharmaceuticals, Inc. | -402.90M |
| Sarepta Therapeutics, Inc. | 232.40M |
| Rezolute, Inc. | -68.49M |
| GT Biopharma, Inc. | 0.00 |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 142.21M |
| Cash from Financing (Quarterly) | 0.301M |
| Free Cash Flow | -105.39M |
| Free Cash Flow Per Share (Quarterly) | 1.585 |
| Free Cash Flow to Equity (Quarterly) | 141.52M |
| Free Cash Flow to Firm (Quarterly) | 142.17M |
| Free Cash Flow Yield | -3.45% |